Renal Macrocystic Disease

Gene: COL4A5

Amber List (moderate evidence)

COL4A5 (collagen type IV alpha 5 chain)
EnsemblGeneIds (GRCh38): ENSG00000188153
EnsemblGeneIds (GRCh37): ENSG00000188153
OMIM: 303630, Gene2Phenotype
COL4A5 is in 10 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

Discussion with KidGen renal experts (Andrew Mallett and Amali Mallawaarchchi): causative relationship with cystic kidney disease not well established; some conflicting literature. Variants need to be interpreted with caution in the setting of cystic kidney disease (as relatively common in the general population): especially so in relatively young patients (<40yo) with normal GFR and in patients with otherwise typical ADPKD findings (more likely to have missed PKD1/PKD2 variant).
Created: 24 Mar 2025, 1:50 a.m. | Last Modified: 24 Mar 2025, 1:50 a.m.
Panel Version: 0.81

Mode of inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)

Bryony Thompson (Royal Melbourne Hospital)

Green List (high evidence)

Multiple kidney cysts, usually with normal kidney volume, were found in 37% (26/70) of patients with a genetically confirmed AS (COL4A3-5), mostly ADAS. A few patients' kidney volumes were similar to autosomal dominant polycystic kidney disease. The prevalence of cystic kidney phenotype was significantly higher in patients with AS compared to those with IgA nephropathy (42% vs 19%; P=0.002). The cystic phenotype in the AS patients was associated with an older age and lower eGFR levels. Also, other studies reporting COL4A5 variants in individuals with a cystic kidney disease phenotype.
Sources: Literature
Created: 11 Dec 2024, 2:04 a.m.

Mode of inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)

Phenotypes
Alport syndrome MONDO:0018965

Publications

Variants in this GENE are reported as part of current diagnostic practice

Details

Mode of Inheritance
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Amber
  • Literature
Phenotypes
  • Alport syndrome MONDO:0018965
OMIM
303630
Clinvar variants
Variants in COL4A5
Penetrance
None
Publications
Panels with this gene

History Filter Activity

24 Mar 2025, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: col4a5 has been classified as Amber List (Moderate Evidence).

11 Dec 2024, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: col4a5 has been classified as Green List (High Evidence).

11 Dec 2024, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: col4a5 has been classified as Green List (High Evidence).

11 Dec 2024, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: COL4A5 was added gene: COL4A5 was added to Renal Macrocystic Disease. Sources: Literature Mode of inheritance for gene: COL4A5 was set to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males) Publications for gene: COL4A5 were set to 38790225; 38680391; 38514012 Phenotypes for gene: COL4A5 were set to Alport syndrome MONDO:0018965 Review for gene: COL4A5 was set to GREEN gene: COL4A5 was marked as current diagnostic